Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial

Publication | Closed Access

DOI

194

Citations

References

2005

Year

Andreas Polychronis, H D Sinnett, Dimitri Hadjiminas, Hemant Singhal, Janine Mansi, Dharsha Shivapatham, Sami Shousha, Jie Jiang, David Peston, Nigel Barrett,

The Lancet Oncology

Breast OncologyMedicineGynecologyBreast CancerCancer TreatmentOncologyRadiation OncologyPostmenopausal PatientsEndocrine-related Cancer